TY - JOUR
T1 - Orthopedic Surgery and Anesthesiology Surgical Improvement Strategies Project – Phase III Outcomes
AU - Matrka, Alexis K.
AU - Smith, Hugh M.
AU - Amundson, Adam W.
AU - Duncan, Christopher M.
AU - Rueter, Matthew J.
AU - Andrijasevic, Sasa
AU - Hannon, Charles P.
AU - Couch, Cory G.
AU - Sanchez-Sotelo, Joaquin
AU - Trousdale, Robert T.
AU - Abdel, Matthew P.
N1 - Funding Information:
The authors would like to acknowledge the Andrew A. and Mary S. Sugg Professorship in Orthopedic Research for its philanthropic support that made such research possible. Additionally, the authors wish to thank many influential members who supported this multidisciplinary effort including: Adam K. Jacob, MD, Kevin C. Lindeen, APRN, CRNA, DNP, Alyssa S. Bishop, MBA, Leah M. Edquist PA-C, MS, Peter L. Bos, PA-C, Becca L. Gas, MS, Natalie Soukup, PA-C, Jesse Kuseske, PA-C, Rafael Sierra, MD, James L. Ryan, Sarah J. Bell, MSN, MHA, RN, Paul A. Proshek, APRN, CNS, MS, Kelly E. Drilling, MSN, RN, Julie A. Nickelson, MSN, RN, Carrie Anderson, RN, Alayna Vrieze, RN, Heather Pham, RN, Shari L. Bernard, OT, OTD, SCFES, Jane R. O'Koren, MS, PT, DPT, GCS, Katie Traver, PT, Tanya Terman, PT, Jonathan Potter, PT, Jennifer J. Schmit, MHA, Brenda Hyke, Gregory T. Richardson, MSN, RN, Kim Schmidt, RN, Laura J. Myhre, PharmD, RPh, Kathryn W. Zavaleta, MHSA, Roma Merrick, Michelle L. Haugen, Ellory Steinbauer, Mary Klepper, Ashley van de Walker.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2023/5
Y1 - 2023/5
N2 - Background: Our institution initiated the Orthopedic Surgery and Anesthesiology Surgical Improvement Strategies (OASIS) project in 2017 to improve the quality and efficiency for hip and knee arthroplasties. Phase III of this project aimed to: 1) increase same-day discharge (SDD) of primary total joint arthroplasties (TJAs) to 20%; 2) maintain or improve 30-day readmission rates; and 3) realize cost savings and revenue increases. Methods: All primary TJAs performed between 2021 and 2022 represented our study cohort, with those in 2019 (prepandemic) establishing the baseline cohort. A multidisciplinary team met weekly to track project tactics and metrics through the entire episode of care from preoperative surgical visit through 30 days postoperatively. Results: The SDD rate increased from 4% at baseline to 37%, with mean lengths of stay (LOS) decreasing from 1.5 to 0.9 days for all primary TJAs. The 30-day readmission rate decreased to 1.2 from 1.3%. Composite changes in surgical volume and cost reductions equaled $5 million. Conclusion: Application of a multidisciplinary team with health systems engineering tools and methods allowed SDD to increase from 4 to 37% with a mean LOS <1 day, resulting in a $5 million incremental gain in profit at a major academic medical center. Importantly, patient safety was not compromised as 30-day readmission rates remained stable. Level of evidence: III Therapeutic.
AB - Background: Our institution initiated the Orthopedic Surgery and Anesthesiology Surgical Improvement Strategies (OASIS) project in 2017 to improve the quality and efficiency for hip and knee arthroplasties. Phase III of this project aimed to: 1) increase same-day discharge (SDD) of primary total joint arthroplasties (TJAs) to 20%; 2) maintain or improve 30-day readmission rates; and 3) realize cost savings and revenue increases. Methods: All primary TJAs performed between 2021 and 2022 represented our study cohort, with those in 2019 (prepandemic) establishing the baseline cohort. A multidisciplinary team met weekly to track project tactics and metrics through the entire episode of care from preoperative surgical visit through 30 days postoperatively. Results: The SDD rate increased from 4% at baseline to 37%, with mean lengths of stay (LOS) decreasing from 1.5 to 0.9 days for all primary TJAs. The 30-day readmission rate decreased to 1.2 from 1.3%. Composite changes in surgical volume and cost reductions equaled $5 million. Conclusion: Application of a multidisciplinary team with health systems engineering tools and methods allowed SDD to increase from 4 to 37% with a mean LOS <1 day, resulting in a $5 million incremental gain in profit at a major academic medical center. Importantly, patient safety was not compromised as 30-day readmission rates remained stable. Level of evidence: III Therapeutic.
KW - outpatient total joint arthroplasty
KW - primary total hip arthroplasty
KW - primary total knee arthroplasty
KW - primary total shoulder arthroplasty
KW - same-day discharge
UR - https://www.scopus.com/pages/publications/85145314758
U2 - 10.1016/j.arth.2022.11.002
DO - 10.1016/j.arth.2022.11.002
M3 - Article
C2 - 36403718
AN - SCOPUS:85145314758
SN - 0883-5403
VL - 38
SP - 779
EP - 784
JO - Journal of Arthroplasty
JF - Journal of Arthroplasty
IS - 5
ER -